$18.41
+0.14 (+0.77%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+33.9% upside
Low Target
$19.75
Average Target
$24.65
High Target
$31.92
Current Price
$18.41
Current
$18.41
$18.41
Target
$24.65
$24.65
$19.75
$24.65 avg
$31.92
Scenario Analysis
Bear Case
$19.75
7.3%
Low target
Base Case
$24.65
+33.9%
Avg target
Bull Case
$31.92
+73.4%
High target
Risk/Reward
10.1x
Highly favorable
Price in Context
52-Week High
$24.28
-24.2% from high
52-Week Low
$1.33
+1,284.2% from low
50-Day SMA
$7.48
+146.1% vs SMA
200-Day SMA
$3.25
+466.5% vs SMA
RSI (14)
71.9
Overbought
Target vs 52W High
$24.65
+1.5% vs high
Next Earnings Report
Aug 10, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.10
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |